$735 Million is the total value of Eventide Asset Management's 104 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 30.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $22,475,000 | +26.4% | 490,500 | +8.0% | 3.06% | +10.7% |
| MDVN | Buy | MEDIVATION INC | $21,220,000 | +24.6% | 275,300 | +4.1% | 2.89% | +9.2% |
| TRW | TRW AUTOMOTIVE HLDGS CORP | $17,761,000 | +9.7% | 198,400 | 0.0% | 2.42% | -3.9% | |
| PANW | PALO ALTO NETWORKS INC | $17,240,000 | +22.2% | 205,600 | 0.0% | 2.34% | +7.1% | |
| EOG | Buy | EOG RES INC | $16,921,000 | +19.1% | 144,800 | +100.0% | 2.30% | +4.4% |
| ABBV | Buy | ABBVIE INC | $16,520,000 | +11.7% | 292,700 | +1.7% | 2.25% | -2.1% |
| SUNEQ | SUNEDISON INC | $16,478,000 | +20.0% | 729,100 | 0.0% | 2.24% | +5.1% | |
| CELG | New | CELGENE CORP | $16,317,000 | – | 190,000 | +100.0% | 2.22% | – |
| MGA | MAGNA INTL INC | $16,130,000 | +11.9% | 149,700 | 0.0% | 2.19% | -2.0% | |
| MIC | MACQUARIE INFRASTR CO LLCmembership int | $15,917,000 | +8.9% | 255,200 | 0.0% | 2.16% | -4.6% | |
| WBC | Buy | WABCO HLDGS INC | $15,713,000 | +15.9% | 147,100 | +14.6% | 2.14% | +1.6% |
| RHT | Buy | RED HAT INC | $14,790,000 | +20.2% | 267,600 | +15.2% | 2.01% | +5.2% |
| LEA | LEAR CORP | $14,372,000 | +6.7% | 160,900 | 0.0% | 1.95% | -6.6% | |
| LLTC | Buy | LINEAR TECHNOLOGY CORP | $13,773,000 | +3.5% | 292,600 | +7.1% | 1.87% | -9.3% |
| SYNA | New | SYNAPTICS INC | $13,333,000 | – | 147,100 | +100.0% | 1.81% | – |
| CBI | CHICAGO BRIDGE & IRON CO N V | $13,217,000 | -21.7% | 193,800 | 0.0% | 1.80% | -31.5% | |
| ROC | ROCKWOOD HLDGS INC | $12,949,000 | +2.1% | 170,400 | 0.0% | 1.76% | -10.5% | |
| DYAX | Buy | DYAX CORP | $12,772,000 | +11.3% | 1,330,400 | +4.1% | 1.74% | -2.5% |
| TEX | TEREX CORP NEW | $12,474,000 | -7.2% | 303,500 | 0.0% | 1.70% | -18.7% | |
| MEOH | METHANEX CORP | $12,436,000 | -3.4% | 201,300 | 0.0% | 1.69% | -15.4% | |
| FPRX | Buy | FIVE PRIME THERAPEUTICS INC | $12,029,000 | +19.2% | 773,600 | +50.7% | 1.64% | +4.5% |
| WAB | Buy | WABTEC CORP | $11,951,000 | +13.6% | 144,700 | +6.6% | 1.62% | -0.5% |
| STKL | Buy | SUNOPTA INC | $11,751,000 | +21.0% | 834,600 | +1.5% | 1.60% | +6.0% |
| LOW | LOWES COS INC | $11,633,000 | -1.9% | 242,400 | 0.0% | 1.58% | -14.0% | |
| CPN | Buy | CALPINE CORP | $11,360,000 | +28.1% | 477,100 | +12.5% | 1.54% | +12.2% |
| LYB | LYONDELLBASELL INDUSTRIES N | $11,122,000 | +9.8% | 113,900 | 0.0% | 1.51% | -3.9% | |
| UFS | Buy | DOMTAR CORP | $11,081,000 | -23.6% | 258,600 | +100.0% | 1.51% | -33.1% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $10,867,000 | +15.4% | 372,400 | +2.4% | 1.48% | +1.1% |
| DATA | New | TABLEAU SOFTWARE INCcl a | $10,707,000 | – | 150,100 | +100.0% | 1.46% | – |
| ININ | Buy | INTERACTIVE INTELLIGENCE GRO | $10,339,000 | -16.6% | 184,200 | +7.8% | 1.41% | -26.9% |
| CXP | Buy | COLUMBIA PPTY TR INC | $10,243,000 | +11.9% | 393,800 | +17.3% | 1.39% | -2.0% |
| CCI | CROWN CASTLE INTL CORP | $9,706,000 | +0.7% | 130,700 | 0.0% | 1.32% | -11.8% | |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $9,560,000 | +103.1% | 423,200 | +118.7% | 1.30% | +77.8% |
| VMW | Buy | VMWARE INC | $9,468,000 | +11.5% | 97,800 | +24.4% | 1.29% | -2.3% |
| NRG | Buy | NRG ENERGY INC | $9,426,000 | +53.3% | 253,400 | +31.0% | 1.28% | +34.2% |
| LGND | Buy | LIGAND PHARMACEUTICALS INC | $9,325,000 | -6.3% | 149,700 | +1.2% | 1.27% | -17.9% |
| IPHI | Buy | INPHI CORP | $9,310,000 | -4.1% | 634,200 | +5.1% | 1.27% | -16.0% |
| CMRX | Buy | CHIMERIX INC | $9,184,000 | -2.4% | 418,600 | +1.6% | 1.25% | -14.5% |
| SDRL | Buy | SEADRILL LIMITED | $9,169,000 | +18.8% | 229,500 | +4.6% | 1.25% | +4.1% |
| NVAX | Buy | NOVAVAX INC | $8,818,000 | +11.8% | 1,908,700 | +9.6% | 1.20% | -2.0% |
| ASML | ASML HOLDINGS NV | $8,749,000 | -0.1% | 93,800 | 0.0% | 1.19% | -12.4% | |
| CMRE | COSTAMARE INC | $8,400,000 | +8.5% | 360,200 | 0.0% | 1.14% | -5.0% | |
| STML | Buy | STEMLINE THERAPEUTICS INC | $8,212,000 | +11.3% | 559,800 | +54.5% | 1.12% | -2.4% |
| BWA | Buy | BORGWARNER INC | $8,188,000 | +18.3% | 125,600 | +11.5% | 1.11% | +3.5% |
| OII | OCEANEERING INTL INC | $8,118,000 | +8.7% | 103,900 | 0.0% | 1.10% | -4.7% | |
| SRPT | SAREPTA THERAPEUTICS INC | $7,719,000 | +24.0% | 259,100 | 0.0% | 1.05% | +8.6% | |
| PCYC | Sell | PHARMACYCLICS INC | $7,410,000 | -33.6% | 82,600 | -25.9% | 1.01% | -41.8% |
| P103PS | Sell | NPS PHARMACEUTICALS INC | $7,400,000 | -12.9% | 223,900 | -21.1% | 1.01% | -23.7% |
| SGMO | Buy | SANGAMO BIOSCIENCES INC | $7,368,000 | -11.9% | 482,500 | +4.3% | 1.00% | -22.8% |
| AYR | AIRCASTLE LTD | $7,101,000 | -8.3% | 399,600 | 0.0% | 0.97% | -19.6% | |
| KAR | KAR AUCTION SVCS INC | $6,776,000 | +5.0% | 212,600 | 0.0% | 0.92% | -8.1% | |
| FC | FRANKLIN COVEY CO | $6,353,000 | +1.8% | 315,600 | 0.0% | 0.86% | -10.8% | |
| PWR | Buy | QUANTA SVCS INC | $6,321,000 | +27.8% | 182,800 | +36.4% | 0.86% | +12.0% |
| TSLA | TESLA MTRS INC | $6,314,000 | +15.2% | 26,300 | 0.0% | 0.86% | +0.9% | |
| SCTY | Sell | SOLARCITY CORP | $6,283,000 | -12.0% | 89,000 | -21.9% | 0.85% | -22.9% |
| AZPN | ASPEN TECHNOLOGY INC | $5,962,000 | +9.5% | 128,500 | 0.0% | 0.81% | -4.0% | |
| NLNK | NEWLINK GENETICS CORP | $5,727,000 | -6.5% | 215,700 | 0.0% | 0.78% | -18.1% | |
| AGTC | New | APPLIED GENETIC TECHNOL CORP | $4,747,000 | – | 205,500 | +100.0% | 0.65% | – |
| CLDX | CELLDEX THERAPEUTICS INC NEW | $4,712,000 | -7.6% | 288,700 | 0.0% | 0.64% | -19.1% | |
| AKBA | New | AKEBIA THERAPEUTICS INC | $4,619,000 | – | 166,200 | +100.0% | 0.63% | – |
| SZYM | Buy | SOLAZYME INC | $4,528,000 | +7.1% | 384,400 | +5.6% | 0.62% | -6.1% |
| TTPH | TETRAPHASE PHARMACEUTICALS I | $4,059,000 | +23.9% | 300,900 | 0.0% | 0.55% | +8.4% | |
| CGNX | New | COGNEX CORP | $3,840,000 | – | 100,000 | +100.0% | 0.52% | – |
| MGNX | Buy | MACROGENICS INC | $3,581,000 | +129.0% | 164,800 | +193.2% | 0.49% | +100.4% |
| BLUE | Buy | BLUEBIRD BIO INC | $2,966,000 | +100.7% | 76,900 | +18.3% | 0.40% | +76.0% |
| ATRC | Buy | ATRICURE INC | $2,799,000 | +3.5% | 152,300 | +5.9% | 0.38% | -9.3% |
| SLXP | Buy | SALIX PHARMACEUTICALS INC | $2,689,000 | +26.6% | 21,800 | +6.3% | 0.37% | +10.9% |
| GWPH | New | GW PHARMACEUTICALS PLCads | $2,682,000 | – | 25,000 | +100.0% | 0.36% | – |
| VCYT | New | VERACYTE INC | $2,648,000 | – | 154,700 | +100.0% | 0.36% | – |
| SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $2,635,000 | +36.7% | 240,600 | +11.6% | 0.36% | +19.7% |
| RARE | New | ULTRAGENYX PHARMACEUTICAL IN | $2,361,000 | – | 52,600 | +100.0% | 0.32% | – |
| RGEN | Buy | REPLIGEN CORP | $2,265,000 | +227.8% | 99,400 | +85.1% | 0.31% | +187.9% |
| XLRN | New | ACCELERON PHARMA INC | $2,110,000 | – | 62,100 | +100.0% | 0.29% | – |
| CBST | Buy | CUBIST PHARMACEUTICALS INC | $2,025,000 | +1.0% | 29,000 | +5.8% | 0.28% | -11.6% |
| CERN | Buy | CERNER CORP | $2,006,000 | -3.1% | 38,900 | +5.7% | 0.27% | -15.0% |
| HPTX | Buy | HYPERION THERAPEUTICS INC | $1,991,000 | +7.6% | 76,300 | +6.4% | 0.27% | -5.6% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $1,879,000 | -2.0% | 30,200 | +7.5% | 0.26% | -14.1% |
| NTUS | Buy | NATUS MEDICAL INC DEL | $1,886,000 | +2.8% | 75,000 | +5.5% | 0.26% | -10.2% |
| BRKR | BRUKER CORP | $1,794,000 | +6.5% | 73,900 | 0.0% | 0.24% | -6.5% | |
| SAAS | INCONTACT INC | $1,776,000 | -4.3% | 193,300 | 0.0% | 0.24% | -16.0% | |
| INSM | Buy | INSMED INC | $1,770,000 | +29.1% | 88,600 | +23.1% | 0.24% | +13.1% |
| CEMP | Buy | CEMPRA INC | $1,650,000 | -0.2% | 153,800 | +7.4% | 0.22% | -12.8% |
| CSII | CARDIOVASCULAR SYS INC DEL | $1,642,000 | -2.0% | 52,700 | 0.0% | 0.22% | -14.2% | |
| DRNA | New | DICERNA PHARMACEUTICALS INC | $1,438,000 | – | 63,700 | +100.0% | 0.20% | – |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $1,434,000 | +2.0% | 96,600 | +10.7% | 0.20% | -10.6% |
| ACRX | ACELRX PHARMACEUTICALS INC | $1,429,000 | -14.6% | 139,400 | 0.0% | 0.19% | -25.4% | |
| VSAR | New | VERSARTIS INC | $1,402,000 | – | 50,000 | +100.0% | 0.19% | – |
| KPTI | Sell | KARYOPHARM THERAPEUTICS INC | $1,397,000 | -33.3% | 30,000 | -55.8% | 0.19% | -41.5% |
| ATHN | Buy | ATHENAHEALTH INC | $1,389,000 | -2.6% | 11,100 | +24.7% | 0.19% | -14.5% |
| FEIC | FEI CO | $1,343,000 | -11.9% | 14,800 | 0.0% | 0.18% | -22.8% | |
| MEIP | Buy | MEI PHARMA INC | $1,278,000 | -15.6% | 201,600 | +48.1% | 0.17% | -26.0% |
| TGTX | New | TG THERAPEUTICS INC | $1,268,000 | – | 135,000 | +100.0% | 0.17% | – |
| OMED | ONCOMED PHARMACEUTICALS INC | $1,230,000 | -30.8% | 52,800 | 0.0% | 0.17% | -39.5% | |
| PCRX | PACIRA PHARMACEUTICALS INC | $1,222,000 | +31.3% | 13,300 | 0.0% | 0.17% | +14.5% | |
| ARWR | New | ARROWHEAD RESH CORP | $1,145,000 | – | 80,000 | +100.0% | 0.16% | – |
| AMBI | Buy | AMBIT BIOSCIENCES CORP | $1,044,000 | -12.7% | 151,100 | +15.3% | 0.14% | -23.7% |
| XOMA | Sell | XOMA Corp | $813,000 | -39.3% | 177,200 | -31.1% | 0.11% | -46.6% |
| MDSO | MEDIDATA SOLUTIONS INC | $809,000 | -21.2% | 18,900 | 0.0% | 0.11% | -30.8% | |
| AEGR | New | AEGERION PHARMACEUTICALS INC | $642,000 | – | 20,000 | +100.0% | 0.09% | – |
| TFX | TELEFLEX INC | $612,000 | -1.6% | 5,800 | 0.0% | 0.08% | -14.4% | |
| SNSS | SUNESIS PHARMACEUTICALS INC | $599,000 | -1.3% | 91,800 | 0.0% | 0.08% | -13.8% | |
| RPTP | RAPTOR PHARMACEUTICAL CORP | $467,000 | +15.6% | 40,400 | 0.0% | 0.06% | +1.6% | |
| QURE | New | UNIQURE NV | $292,000 | – | 21,466 | +100.0% | 0.04% | – |
| VSTM | New | VERASTEM INC | $189,000 | – | 20,900 | +100.0% | 0.03% | – |
| HTWR | Exit | HEARTWARE INTL INC | $0 | – | -3,100 | -100.0% | -0.04% | – |
| RMD | Exit | RESMED INC | $0 | – | -9,900 | -100.0% | -0.07% | – |
| CERS | Exit | CERUS CORP | $0 | – | -97,800 | -100.0% | -0.07% | – |
| MDAS | Exit | MEDASSETS INC | $0 | – | -26,500 | -100.0% | -0.10% | – |
| ATHX | Exit | ATHERSYS INC | $0 | – | -265,300 | -100.0% | -0.13% | – |
| COG | Exit | CABOT OIL & GAS CORP | $0 | – | -35,200 | -100.0% | -0.18% | – |
| SHPG | Exit | SHIRE PLCsponsored adr | $0 | – | -9,800 | -100.0% | -0.23% | – |
| FMI | Exit | FOUNDATION MEDICINE INC | $0 | – | -49,200 | -100.0% | -0.25% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -28,300 | -100.0% | -0.30% | – |
| PRTA | Exit | PROTHENA CORP PLC | $0 | – | -58,300 | -100.0% | -0.35% | – |
| ECYT | Exit | ENDOCYTE INC | $0 | – | -98,000 | -100.0% | -0.36% | – |
| NOV | Exit | NATIONAL OILWELL VARCO INC | $0 | – | -47,500 | -100.0% | -0.57% | – |
| SJM | Exit | SMUCKER J M CO | $0 | – | -46,400 | -100.0% | -0.70% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -44,900 | -100.0% | -0.73% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-08-14
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LOWES COS INC | 40 | Q3 2023 | 3.2% |
| PALO ALTO NETWORKS INC | 40 | Q3 2023 | 3.6% |
| ASML HOLDINGS NV | 40 | Q3 2023 | 1.9% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
| REPLIGEN CORP | 40 | Q3 2023 | 0.5% |
| VERACYTE INC | 38 | Q3 2023 | 1.5% |
| LAM RESEARCH CORP | 35 | Q3 2023 | 3.4% |
| XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.6% |
| MAGNA INTL INC | 33 | Q4 2021 | 2.5% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cogent Biosciences, Inc. | February 14, 2023 | 2,589,778 | 3.7% |
| ESSA Pharma Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Freeline Therapeutics Holdings plc | February 14, 2023 | 5,920,765 | 9.1% |
| KnowBe4, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Praxis Precision Medicines, Inc. | February 14, 2023 | 3,518,062 | 7.5% |
| Prometheus Biosciences, Inc. | February 14, 2023 | 1,032,938 | 2.2% |
| SUTRO BIOPHARMA, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Vital Farms, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Zymeworks Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Entasis Therapeutics Holdings Inc. | February 14, 2022 | 590,602 | 1.2% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.